메뉴 건너뛰기




Volumn 20, Issue 2, 2005, Pages 118-124

A realistic chance for gene therapy in the near future

Author keywords

Clinical trials; Gene therapy; Gene transfer vectors

Indexed keywords

ALPHA 1 ANTITRYPSIN; BLOOD CLOTTING FACTOR 9; BONE MORPHOGENETIC PROTEIN 4; CATION; CD40 LIGAND; DNA; GENE PRODUCT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 2; LENTIVIRUS VECTOR; LIPOSOME; MDA7 PROTEIN; ORNITHINE CARBAMOYLTRANSFERASE; PARVOVIRUS VECTOR; PLASMID DNA; PLASMID VECTOR; PROTEIN INHIBITOR; PROTEIN P16; PROTEIN P53; RECOMBINANT DNA; RETROVIRUS VECTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VIRUS VACCINE;

EID: 12944258914     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1680-0     Document Type: Editorial
Times cited : (19)

References (69)
  • 1
    • 0032580348 scopus 로고    scopus 로고
    • Human gene therapy
    • 10.1038/32801
    • Anderson WF (1998) Human gene therapy. Nature 392:25-30 10.1038/32801
    • (1998) Nature , vol.392 , pp. 25-30
    • Anderson, W.F.1
  • 2
    • 0027595949 scopus 로고
    • The basic science of gene therapy
    • 1:CAS:528:DyaK3sXktVSisbg%3D
    • Mulligan RC (1993) The basic science of gene therapy. Science 260:926-932 1:CAS:528:DyaK3sXktVSisbg%3D
    • (1993) Science , vol.260 , pp. 926-932
    • Mulligan, R.C.1
  • 3
    • 0028875936 scopus 로고
    • Transfer of genes to humans: Early lessons and obstacles to success
    • 1:CAS:528:DyaK2MXovVeku7s%3D
    • Crystal RG (1995) Transfer of genes to humans: Early lessons and obstacles to success. Science 270:404-410 1:CAS:528:DyaK2MXovVeku7s%3D
    • (1995) Science , vol.270 , pp. 404-410
    • Crystal, R.G.1
  • 4
    • 0038311930 scopus 로고    scopus 로고
    • Current status of gene therapy for inherited lung diseases
    • 10.1146/annurev.physiol.65.092101.142426
    • Driskell RA, Engelhardt JF (2003) Current status of gene therapy for inherited lung diseases. Annu Rev Physiol 65:585-612 10.1146/annurev.physiol.65.092101.142426
    • (2003) Annu. Rev. Physiol. , vol.65 , pp. 585-612
    • Driskell, R.A.1    Engelhardt, J.F.2
  • 5
    • 0038745599 scopus 로고    scopus 로고
    • Progress and problems with the use of viral vectors for gene therapy
    • 10.1038/nrg1066
    • Thomas CE, Ehrhardt A, Kay MA (2003) Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4:346-358 10.1038/nrg1066
    • (2003) Nat. Rev. Genet. , vol.4 , pp. 346-358
    • Thomas, C.E.1    Ehrhardt, A.2    Kay, M.A.3
  • 7
    • 0142089747 scopus 로고    scopus 로고
    • Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
    • 10.1016/j.ymgme.2003.08.016
    • Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP, Wilson JM, Batshaw ML (2003) Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 80:148-158 10.1016/j.ymgme.2003.08.016
    • (2003) Mol. Genet. Metab. , vol.80 , pp. 148-158
    • Raper, S.E.1    Chirmule, N.2    Lee, F.S.3    Wivel, N.A.4    Bagg, A.5    Gao, G.P.6    Wilson, J.M.7    Batshaw, M.L.8
  • 8
    • 0033844756 scopus 로고    scopus 로고
    • Antivector and antitransgene host responses in gene therapy
    • 1:CAS:528:DC%2BD3cXmtl2qtrs%3D
    • Hackett NR, Kaminsky SM, Sondhi D, Crystal RG (2000) Antivector and antitransgene host responses in gene therapy. Curr Opin Mol Ther 2:376-382 1:CAS:528:DC%2BD3cXmtl2qtrs%3D
    • (2000) Curr. Opin. Mol. Ther. , vol.2 , pp. 376-382
    • Hackett, N.R.1    Kaminsky, S.M.2    Sondhi, D.3    Crystal, R.G.4
  • 10
    • 1342289322 scopus 로고    scopus 로고
    • Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency
    • 10.1056/NEJMra032207
    • McCormack MP, Rabbitts TH (2004) Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 350:913-922 10.1056/NEJMra032207
    • (2004) N. Engl. J. Med. , vol.350 , pp. 913-922
    • McCormack, M.P.1    Rabbitts, T.H.2
  • 11
    • 2342453844 scopus 로고    scopus 로고
    • Gene therapy in renal diseases
    • 10.1111/j.1523-1755.2004.05409.x
    • Imai E, Takabatake Y, Mizui M, Isaka Y (2004) Gene therapy in renal diseases. Kidney Int 65:1551-1555 10.1111/j.1523-1755.2004.05409.x
    • (2004) Kidney Int. , vol.65 , pp. 1551-1555
    • Imai, E.1    Takabatake, Y.2    Mizui, M.3    Isaka, Y.4
  • 12
    • 0038102806 scopus 로고    scopus 로고
    • Applications of gene therapy to kidney disease
    • 10.1097/00041552-200307000-00013
    • Hanss B, Bruggeman LA (2003) Applications of gene therapy to kidney disease. Curr Opin Nephrol Hypertens 12:439-445 10.1097/00041552-200307000-00013
    • (2003) Curr. Opin. Nephrol. Hypertens. , vol.12 , pp. 439-445
    • Hanss, B.1    Bruggeman, L.A.2
  • 13
    • 0038115345 scopus 로고    scopus 로고
    • Renal gene transfer: Nonviral approaches
    • 10.1385/MB:24:3:283
    • Lien YH, Lai LW (2003) Renal gene transfer: Nonviral approaches. Mol Biotechnol 24:283-294 10.1385/MB:24:3:283
    • (2003) Mol. Biotechnol. , vol.24 , pp. 283-294
    • Lien, Y.H.1    Lai, L.W.2
  • 17
    • 0042665422 scopus 로고    scopus 로고
    • Targeting retroviral and lentiviral vectors
    • 1:CAS:528:DC%2BD3sXotFClt78%3D
    • Sandrin V, Russell SJ, Cosset FL (2003) Targeting retroviral and lentiviral vectors. Curr Top Microbiol Immunol 281:137-178 1:CAS:528:DC%2BD3sXotFClt78%3D
    • (2003) Curr. Top. Microbiol. Immunol. , vol.281 , pp. 137-178
    • Sandrin, V.1    Russell, S.J.2    Cosset, F.L.3
  • 18
    • 0036968169 scopus 로고    scopus 로고
    • Gene delivery using herpes simplex virus vectors
    • 10.1089/104454902762053864
    • Burton EA, Fink DJ, Glorioso JC (2002) Gene delivery using herpes simplex virus vectors. DNA Cell Biol 21:915-936 10.1089/104454902762053864
    • (2002) DNA Cell Biol. , vol.21 , pp. 915-936
    • Burton, E.A.1    Fink, D.J.2    Glorioso, J.C.3
  • 19
    • 0000557447 scopus 로고    scopus 로고
    • Adenoviridae: The viruses and their replication
    • Fields BN, Knipe DM, Howley PM (eds) Lippincott-Raven, Philadelphia
    • Shenk T (1996) Adenoviridae: The viruses and their replication. In: Fields BN, Knipe DM, Howley PM (eds) Fields virology. Lippincott-Raven, Philadelphia, pp 2111-2148
    • (1996) Fields Virology , pp. 2111-2148
    • Shenk, T.1
  • 24
    • 0642366702 scopus 로고    scopus 로고
    • Gene therapy for human malignant brain tumors
    • 1:CAS:528:DC%2BD3sXnsFyjtrg%3D
    • Rainov NG, Ren H (2003) Gene therapy for human malignant brain tumors. Cancer J 9:180-188 1:CAS:528:DC%2BD3sXnsFyjtrg%3D
    • (2003) Cancer J. , vol.9 , pp. 180-188
    • Rainov, N.G.1    Ren, H.2
  • 25
    • 0141958608 scopus 로고    scopus 로고
    • Gene therapy using an adenovirus vector for apoptosis-related genes is a highly effective therapeutic modality for killing glioma cells
    • 1:CAS:528:DC%2BD3sXitFyrsrc%3D
    • Shinoura N, Hamada H (2003) Gene therapy using an adenovirus vector for apoptosis-related genes is a highly effective therapeutic modality for killing glioma cells. Curr Gene Ther 3:147-153 1:CAS:528:DC%2BD3sXitFyrsrc%3D
    • (2003) Curr. Gene Ther. , vol.3 , pp. 147-153
    • Shinoura, N.1    Hamada, H.2
  • 26
    • 0042827491 scopus 로고    scopus 로고
    • Comparison of replication-selective, oncolytic viruses for the treatment of human cancers
    • 14513677
    • Wildner O (2003) Comparison of replication-selective, oncolytic viruses for the treatment of human cancers. Curr Opin Mol Ther 5:351-361 14513677
    • (2003) Curr. Opin. Mol. Ther. , vol.5 , pp. 351-361
    • Wildner, O.1
  • 28
    • 0037297359 scopus 로고    scopus 로고
    • Gene therapy progress and prospects: Therapeutic angiogenesis for limb and myocardial ischemia
    • 10.1038/sj.gt.3301969
    • Khan TA, Sellke FW, Laham RJ (2003) Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia. Gene Ther 10:285-291 10.1038/sj.gt.3301969
    • (2003) Gene Ther. , vol.10 , pp. 285-291
    • Khan, T.A.1    Sellke, F.W.2    Laham, R.J.3
  • 29
    • 0029951519 scopus 로고    scopus 로고
    • A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier
    • 10.1006/viro.1996.0239
    • Xiang ZQ, Yang Y, Wilson JM, Ertl HC (1996) A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219:220-227 10.1006/viro.1996.0239
    • (1996) Virology , vol.219 , pp. 220-227
    • Xiang, Z.Q.1    Yang, Y.2    Wilson, J.M.3    Ertl, H.C.4
  • 30
    • 1542299092 scopus 로고    scopus 로고
    • Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors
    • 10.1146/annurev.med.55.091902.104344
    • Shiver JW, Emini EA (2004) Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. Annu Rev Med 55:355-372 10.1146/annurev.med.55.091902.104344
    • (2004) Annu. Rev. Med. , vol.55 , pp. 355-372
    • Shiver, J.W.1    Emini, E.A.2
  • 33
    • 0034782151 scopus 로고    scopus 로고
    • High-capacity 'gutless' adenoviral vectors
    • 1:CAS:528:DC%2BD3MXotlyqtbg%3D
    • Kochanek S, Schiedner G, Volpers C (2001) High-capacity 'gutless' adenoviral vectors. Curr Opin Mol Ther 3:454-463 1:CAS:528:DC%2BD3MXotlyqtbg%3D
    • (2001) Curr. Opin. Mol. Ther. , vol.3 , pp. 454-463
    • Kochanek, S.1    Schiedner, G.2    Volpers, C.3
  • 34
    • 0031916435 scopus 로고    scopus 로고
    • Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity
    • 10.1038/ng0298-180
    • Schiedner G, Morral N, Parks RJ, Wu Y, Koopmans SC, Langston C, Graham FL, Beaudet AL, Kochanek S (1998) Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 18:180-183 10.1038/ng0298-180
    • (1998) Nat. Genet. , vol.18 , pp. 180-183
    • Schiedner, G.1    Morral, N.2    Parks, R.J.3    Wu, Y.4    Koopmans, S.C.5    Langston, C.6    Graham, F.L.7    Beaudet, A.L.8    Kochanek, S.9
  • 35
    • 0033643006 scopus 로고    scopus 로고
    • Molecular biology of adeno-associated viruses
    • 1:CAS:528:DC%2BD3cXntFKltLw%3D
    • Linden RM, Berns KI (2000) Molecular biology of adeno-associated viruses. Contrib Microbiol 4:68-84 1:CAS:528:DC%2BD3cXntFKltLw%3D
    • (2000) Contrib. Microbiol. , vol.4 , pp. 68-84
    • Linden, R.M.1    Berns, K.I.2
  • 36
    • 1542369977 scopus 로고    scopus 로고
    • From virus evolution to vector revolution: Use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy
    • 1:CAS:528:DC%2BD3sXlsVSjs7g%3D
    • Grimm D, Kay MA (2003) From virus evolution to vector revolution: Use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr Gene Ther 3:281-304 1:CAS:528:DC%2BD3sXlsVSjs7g%3D
    • (2003) Curr. Gene Ther. , vol.3 , pp. 281-304
    • Grimm, D.1    Kay, M.A.2
  • 38
    • 0142154212 scopus 로고    scopus 로고
    • AAV-mediated gene therapy for hemophilia
    • 1:CAS:528:DC%2BD3sXptFKitLk%3D
    • Couto LB, Pierce GF (2003) AAV-mediated gene therapy for hemophilia. Curr Opin Mol Ther 5:517-523 1:CAS:528:DC%2BD3sXptFKitLk%3D
    • (2003) Curr. Opin. Mol. Ther. , vol.5 , pp. 517-523
    • Couto, L.B.1    Pierce, G.F.2
  • 41
    • 0028169741 scopus 로고
    • Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain
    • 10.1038/ng1094-148
    • Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ (1994) Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 8:148-154 10.1038/ng1094-148
    • (1994) Nat. Genet. , vol.8 , pp. 148-154
    • Kaplitt, M.G.1    Leone, P.2    Samulski, R.J.3    Xiao, X.4    Pfaff, D.W.5    O'Malley, K.L.6    During, M.J.7
  • 42
    • 1542740191 scopus 로고    scopus 로고
    • AAV-mediated gene transfer to skeletal muscle
    • 1:CAS:528:DC%2BD3sXpsVWksLY%3D
    • Herzog RW (2004) AAV-mediated gene transfer to skeletal muscle. Methods Mol Biol 246:179-194 1:CAS:528:DC%2BD3sXpsVWksLY%3D
    • (2004) Methods Mol. Biol. , vol.246 , pp. 179-194
    • Herzog, R.W.1
  • 45
    • 1542740116 scopus 로고    scopus 로고
    • Gene delivery by lentivirus vectors. An overview
    • 1:CAS:528:DC%2BD3sXpsVWktr8%3D
    • Kafri T (2004) Gene delivery by lentivirus vectors. An overview. Methods Mol Biol 246:367-390 1:CAS:528:DC%2BD3sXpsVWktr8%3D
    • (2004) Methods Mol. Biol. , vol.246 , pp. 367-390
    • Kafri, T.1
  • 46
    • 0036819745 scopus 로고    scopus 로고
    • Therapeutic globin gene delivery using lentiviral vectors
    • 1:CAS:528:DC%2BD3sXhtlKkt7g%3D
    • Rivella S, Sadelain M (2002) Therapeutic globin gene delivery using lentiviral vectors. Curr Opin Mol Ther 4:505-514 1:CAS:528:DC%2BD3sXhtlKkt7g%3D
    • (2002) Curr. Opin. Mol. Ther. , vol.4 , pp. 505-514
    • Rivella, S.1    Sadelain, M.2
  • 47
    • 0142227237 scopus 로고    scopus 로고
    • Targeting survival: Integration site selection by retroviruses and LTR-retrotransposons
    • 10.1016/S0092-8674(03)00760-8
    • Bushman FD (2003) Targeting survival: Integration site selection by retroviruses and LTR-retrotransposons. Cell 115:135-138 10.1016/S0092-8674(03)00760-8
    • (2003) Cell , vol.115 , pp. 135-138
    • Bushman, F.D.1
  • 48
    • 3342878376 scopus 로고    scopus 로고
    • Prospects and implications of using chromatin insulators in gene therapy and transgenesis
    • 10.1002/bies.20059
    • Recillas-Targa F, Valadez-Graham V, Farrell CM (2004) Prospects and implications of using chromatin insulators in gene therapy and transgenesis. Bioessays 26:796-807 10.1002/bies.20059
    • (2004) Bioessays , vol.26 , pp. 796-807
    • Recillas-Targa, F.1    Valadez-Graham, V.2    Farrell, C.M.3
  • 49
    • 0037841763 scopus 로고    scopus 로고
    • Transcription start regions in the human genome are favored targets for MLV integration
    • 10.1126/science.1083413
    • Wu X, Li Y, Crise B, Burgess SM (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science 300:1749-1751 10.1126/science.1083413
    • (2003) Science , vol.300 , pp. 1749-1751
    • Wu, X.1    Li, Y.2    Crise, B.3    Burgess, S.M.4
  • 50
    • 0037790709 scopus 로고    scopus 로고
    • Immune responses to replication-defective HSV-1 type vectors within the CNS: Implications for gene therapy
    • 10.1038/sj.gt.3302047
    • Bowers WJ, Olschowka JA, Federoff HJ (2003) Immune responses to replication-defective HSV-1 type vectors within the CNS: Implications for gene therapy. Gene Ther 10:941-945 10.1038/sj.gt.3302047
    • (2003) Gene Ther. , vol.10 , pp. 941-945
    • Bowers, W.J.1    Olschowka, J.A.2    Federoff, H.J.3
  • 51
    • 0033579358 scopus 로고    scopus 로고
    • Gene therapy death prompts review of adenovirus vector
    • 10.1126/science.286.5448.2244
    • Marshall E (1999) Gene therapy death prompts review of adenovirus vector. Science 286:2244-2245 10.1126/science.286.5448.2244
    • (1999) Science , vol.286 , pp. 2244-2245
    • Marshall, E.1
  • 54
    • 0742307402 scopus 로고    scopus 로고
    • Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults
    • 10.1089/10430340460732490
    • Flotte TR, Brantly ML, Spencer LT, Byrne BJ, Spencer CT, Baker DJ, Humphries M (2004) Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults. Hum Gene Ther 15:93-128 10.1089/10430340460732490
    • (2004) Hum. Gene Ther. , vol.15 , pp. 93-128
    • Flotte, T.R.1    Brantly, M.L.2    Spencer, L.T.3    Byrne, B.J.4    Spencer, C.T.5    Baker, D.J.6    Humphries, M.7
  • 56
    • 2342457825 scopus 로고    scopus 로고
    • Clinical gene transfer studies for hemophilia B
    • 10.1055/s-2004-825639
    • High KA (2004) Clinical gene transfer studies for hemophilia B. Semin Thromb Hemost 30:257-267 10.1055/s-2004-825639
    • (2004) Semin. Thromb. Hemost. , vol.30 , pp. 257-267
    • High, K.A.1
  • 58
    • 0034849318 scopus 로고    scopus 로고
    • Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation
    • 10.1006/mthe.2001.0442
    • Herzog RW, Mount JD, Arruda VR, High KA, Lothrop CD Jr (2001) Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation. Mol Ther 4:192-200 10.1006/mthe.2001.0442
    • (2001) Mol. Ther. , vol.4 , pp. 192-200
    • Herzog, R.W.1    Mount, J.D.2    Arruda, V.R.3    High, K.A.4    Lothrop Jr., C.D.5
  • 60
    • 12244274327 scopus 로고    scopus 로고
    • Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract development
    • 10.1046/j.1523-1755.2003.00834.x
    • Miyazaki Y, Oshima K, Fogo A, Ichikawa I (2003) Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract development. Kidney Int 63:835-844 10.1046/j.1523-1755.2003.00834.x
    • (2003) Kidney Int. , vol.63 , pp. 835-844
    • Miyazaki, Y.1    Oshima, K.2    Fogo, A.3    Ichikawa, I.4
  • 61
    • 0035164441 scopus 로고    scopus 로고
    • Genetically modified bone marrow-derived vehicle cells site specifically deliver an anti-inflammatory cytokine to inflamed interstitium of obstructive nephropathy
    • 1:CAS:528:DC%2BD3MXis1emsA%3D%3D
    • Yamagishi H, Yokoo T, Imasawa T, Mitarai T, Kawamura T, Utsunomiya Y (2001) Genetically modified bone marrow-derived vehicle cells site specifically deliver an anti-inflammatory cytokine to inflamed interstitium of obstructive nephropathy. J Immunol 166:609-616 1:CAS:528:DC%2BD3MXis1emsA%3D%3D
    • (2001) J. Immunol. , vol.166 , pp. 609-616
    • Yamagishi, H.1    Yokoo, T.2    Imasawa, T.3    Mitarai, T.4    Kawamura, T.5    Utsunomiya, Y.6
  • 62
    • 0037792920 scopus 로고    scopus 로고
    • Gene delivery using human cord blood-derived CD34+cells into inflamed glomeruli in NOD/SCID mice
    • 10.1046/j.1523-1755.2003.00046.x
    • Yokoo T, Ohashi T, Utsunomiya Y, Okamoto A, Suzuki T, Shen JS, Tanaka T, Kawamura T, Hosoya T (2003) Gene delivery using human cord blood-derived CD34+cells into inflamed glomeruli in NOD/SCID mice. Kidney Int 64:102-109 10.1046/j.1523-1755.2003.00046.x
    • (2003) Kidney Int. , vol.64 , pp. 102-109
    • Yokoo, T.1    Ohashi, T.2    Utsunomiya, Y.3    Okamoto, A.4    Suzuki, T.5    Shen, J.S.6    Tanaka, T.7    Kawamura, T.8    Hosoya, T.9
  • 63
    • 0036265537 scopus 로고    scopus 로고
    • Hepatic and renal differentiation from blood-borne stem cells
    • 10.1038/sj.gt.3301720
    • Forbes SJ, Poulsom R, Wright NA (2002) Hepatic and renal differentiation from blood-borne stem cells. Gene Ther 9:625-630 10.1038/sj.gt.3301720
    • (2002) Gene Ther. , vol.9 , pp. 625-630
    • Forbes, S.J.1    Poulsom, R.2    Wright, N.A.3
  • 64
    • 0036261824 scopus 로고    scopus 로고
    • Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors
    • 10.1038/sj.gt.3301723
    • Rafii S, Heissig B, Hattori K (2002) Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors. Gene Ther 9:631-641 10.1038/sj.gt.3301723
    • (2002) Gene Ther. , vol.9 , pp. 631-641
    • Rafii, S.1    Heissig, B.2    Hattori, K.3
  • 66
    • 0032910706 scopus 로고    scopus 로고
    • Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis
    • 10.1046/j.1523-1755.1999.00275.x
    • Isaka Y, Akagi Y, Ando Y, Tsujie M, Sudo T, Ohno N, Border WA, Noble NA, Kaneda Y, Hori M, Imai E (1999) Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 55:465-475 10.1046/j.1523-1755.1999.00275.x
    • (1999) Kidney Int. , vol.55 , pp. 465-475
    • Isaka, Y.1    Akagi, Y.2    Ando, Y.3    Tsujie, M.4    Sudo, T.5    Ohno, N.6    Border, W.A.7    Noble, N.A.8    Kaneda, Y.9    Hori, M.10    Imai, E.11
  • 68
    • 0034026805 scopus 로고    scopus 로고
    • CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft
    • 1:CAS:528:DC%2BD3cXisFertLo%3D
    • Tomasoni S, Azzollini N, Casiraghi F, Capogrossi MC, Remuzzi G, Benigni A (2000) CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft. J Am Soc Nephrol 11:747-752 1:CAS:528:DC%2BD3cXisFertLo%3D
    • (2000) J. Am. Soc. Nephrol. , vol.11 , pp. 747-752
    • Tomasoni, S.1    Azzollini, N.2    Casiraghi, F.3    Capogrossi, M.C.4    Remuzzi, G.5    Benigni, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.